Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | PLAU | P00749 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7045865 | 0.91 | SMN1; SMN2 (0.38) | SMN1; SMN2PLAUHPGDMAPTL3MBTL1 | |
| SCHEMBL26746294 | 0.86 | KDM4E (0.43) | SMN1; SMN2ALDH1A1KDM4EGAATDP1 | |
| SCHEMBL26748925 | 0.86 | KDM4E (0.43) | SMN1; SMN2ALDH1A1KDM4EGAATDP1 | |
| SCHEMBL10990403 | 0.82 | ALDH1A1 (0.53) | SMN1; SMN2HPGDALDH1A1KDM4ETDP1 | |
| SCHEMBL2999427 | 0.81 | ALDH1A1 (0.39) | MAPTALDH1A1KDM4ES1PR1S1PR3 | |
| SCHEMBL19484550 | 0.81 | SMN1; SMN2 (0.51) | SMN1; SMN2HPGDMAPTALDH1A1KDM4E | |
| SCHEMBL26748898 | 0.80 | AR (0.64) | SMN1; SMN2MAPTMAPK1ALDH1A1KDM4E | |
| SCHEMBL26749674 | 0.80 | KDM4E (0.40) | SMN1; SMN2HPGDMAPTALDH1A1KDM4E | |
| SCHEMBL2376058 | 0.79 | MAPT (0.54) | SMN1; SMN2PLAUHPGDMAPTL3MBTL1 | |
| SCHEMBL8997268 | 0.78 | MCL1 (0.47) | SMN1; SMN2PLAUL3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2190812-B1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2015-12-02 | — | — | EP | disclosed |
| US-8426490-B2 | Methacrylate based monomers containing a urethane linkage, process for production and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-23 | — | — | US | disclosed |
| US-20100197824-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2010-08-05 | — | — | US | disclosed |
| EP-2190812-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M Innovative Properties Company (US) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009042574-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-04-02 | — | — | WO | disclosed |
| EP-2042486-A1 | Methacrylate Based Monomers containing a Urethane Linkage, Process for Production and Use thereof | 3M Innovative Properties Company (US) | 2009-04-01 | — | — | EP | disclosed |
| US-4525529-A | HALOGEN-CONTAINING COPOLYMERIC POLYESTER BLENDED WITH MODIFIED ETHYLENE COPOLYMER | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
| US-4454302-A | BLEND WITH HALOGEN CONTAINING ACRYLIC RESIN | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1984-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197824-A1 | METHACRYLATE BASED MONOMERS CONTAINING A URETHANE LINKAGE, PROCESS FOR PRODUCTION AND USE THEREOF | PYM1, B2M, MACF1 | SMN1; SMN2 3319/4885PLAU 4184/4885HPGD 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.